Order Stem Cells
- - - Over 1500+ diverse stem cell lines
      
      WiCell provides over 1500 diverse cell lines including hESC, iPSC, and cGMP cell lines. Search the catalog to find the right cell line for your research.
      
      Learn More
Test Cells
- - - cGMP and research grade testing services
      
      Reliable cGMP and research testing for a variety of stem, immune, and engineered cell types. From bench to clinic, we provide quality assays and quick turn around times to support your needs.
      
      Learn More
Store Cells
Other Services
- - - Let WiCell be your lab partner
      
      Backed by decades of experience and a commitment to quality, WiCell is your lab partner for banking, distribution, and reagent testing, letting you focus on the science while we take care of the rest.
      
      Learn More
Resources
- - - Trusted knowledge. Proven science.
      
      Insights, publications, and updates from WiCell’s team of experts. Whether you’re looking for technical guidance or the latest news, our resources are here to support your research every step of the way.
      
      Learn More
About Us
- - - Built on trust
      
      For over two decades, WiCell has earned the trust of the scientific community through expertise, integrity, and our unending commitment to quality.
      
      Learn More
- - - Search for:

NHLBI Next Gen - Coronary artery disease and myocardial infarction (Dr. Eric Topol, Scripps Research Institute)

NHLBI Next Gen - Coronary artery disease and myocardial infarction (Dr. Eric Topol, Scripps Research Institute)

Showing 97–97 of 97 results

Cell Line	Cell Line Alias	Cell Type	Disease	Genetic Alteration/Mutation	Sex	Age at Collection	Ethnicity	Genetically Related Cell Lines	dbGaP Data
SCRP5707i	HE00043	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Female	86 Years	Caucasian > European	No	No
SCRP5803i	HE00045	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites.	Male	87 Years	Caucasian	No	No
SCRP6007i	HE00065	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Female	88 Years	Caucasian	No	No
SCRP6101i	HE00083	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites.	Female	86 Years	Caucasian	No	No
SCRP6301i	HE00163	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites.	Female	95 Years	Caucasian > European	No	No
SCRP6401i	HE00168	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites.	Female	92 Years	Caucasian > European	No	No
SCRP6504i	HE00170	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites.	Male	88 Years	Caucasian > European	No	No
SCRP6703i	HE00215	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Female	86 Years	Caucasian > European	No	No
SCRP6904i	HE00487	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites.	Female	86 Years	Caucasian > European	No	No
SCRP7301i	HE00569	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites.	Male	85 Years	Caucasian > European	No	No

1…789 10